Thrilled that my paper was mentioned at #PSA22SYD @AmyTPage @cd_ethertonbeer Why medicalise something we don’t have a treatment for? See full article: https://t.co/dP2AxIFcd9 https://t.co/07RYwhulIb
Mild cognitive impairment: To diagnose or not to diagnose.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2021 – Jul 2022Where it's discussed
-
X / Twitter16 posts
-
Reddit4 posts
-
Facebook3 posts
-
YouTube2 videos
AI synopsis
What people are saying
Many discussions revolve around the debate over medicalizing MCI, with comments questioning the value of diagnosis, such as 'Why medicalise something we don’t have a treatment for?' Their tone reflects caution, emphasizing uncertainties and ethical considerations. Examples like questions about the usefulness of diagnosis for patients highlight a cautious interest, with some engagement evident in the exploration of risks versus benefits.
Most discussions express skepticism about diagnosing MCI, questioning its medicalization without clear treatment options.
The discussions show moderate curiosity, focusing on issues like patient benefit and the implications of diagnosis.
Participants engage by raising questions about risks, benefits, and the broader impact of diagnosing MCI, demonstrating thoughtful consideration.
The discussions seem to influence perceptions about the importance and consequences of diagnosing MCI but do not suggest a transformative shift in practice.
Abstract in brief
- Mild cognitive impairment (MCI) involves a slight decline in cognitive function that doesn't yet qualify as dementia, sparking debate about whether it should always be diagnosed.
- Some individuals with MCI improve or remain stable, while others may progress to dementia, but current treatments focus mainly on managing other health conditions and exercise.
- Due to limited evidence on effective treatments and uncertainty about the long-term importance of diagnosing MCI, the value of diagnosing this condition is still unclear.]
Top posts
Most liked on X and BlueskyMild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
Is Mild Cognitive Impairment a diagnosis that's useful to patients? @KateNWang @cd_ethertonbeer https://t.co/sV3T3qzrO0
Some interesting aged care articles https://t.co/ExoaMgzALu https://t.co/9KKEjTcOJx https://t.co/xnqmf3JFUE https://t.co/ipZIjC0yVF https://t.co/TUbLojpkZt https://t.co/mWaRKsWAkG https://t.co/EKORxrgxxK https://t.co/T1k38ydRSs
#NeuroTPA @AmyTPage @KateNWang researchers ask: Should we diagnose Mild Cognitive Impairment (#MCI)? What are the risks/benefits? How will a diagnosis benefit the patient? #TPATuesday https://t.co/s4CtwUQvfx https://t.co/9rRLoY2awn
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
All mentions
Prevalence of Polypharmacy in Older Australians (2006-2017)
This video explores the prevalence of polypharmacy among Australians aged 70 and older from 2006 to 2017. Notably, in 2017, 36.1% of this demographic experienced continuous polypharmacy, indicating significant health…
Impact of Deprescribing on Older Adults' Health Outcomes
This video discusses the potential effects of deprescribing in older adults, focusing on its feasibility and impact on mortality and health. It reviews key findings from systematic research and meta-analysis aimed at…
RT @KateNWang: Thrilled that my paper was mentioned at #PSA22SYD @AmyTPage @cd_ethertonbeer Why medicalise something we don’t have a treat…
RT @KateNWang: Thrilled that my paper was mentioned at #PSA22SYD @AmyTPage @cd_ethertonbeer Why medicalise something we don’t have a treat…
Thrilled that my paper was mentioned at #PSA22SYD @AmyTPage @cd_ethertonbeer Why medicalise something we don’t have a treatment for? See full article: https://t.co/dP2AxIFcd9 https://t.co/07RYwhulIb
RT @HappyResearch66: Some interesting aged care articles https://t.co/ExoaMgzALu https://t.co/9KKEjTcOJx https://t.co/xnqmf3JFUE https://t.…
Some interesting aged care articles https://t.co/ExoaMgzALu https://t.co/9KKEjTcOJx https://t.co/xnqmf3JFUE https://t.co/ipZIjC0yVF https://t.co/TUbLojpkZt https://t.co/mWaRKsWAkG https://t.co/EKORxrgxxK https://t.co/T1k38ydRSs
Mild cognitive impairment: To diagnose or not to diagnose https://t.co/ziwcix3sYw
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
RT @MIPS_Australia: #NeuroTPA @AmyTPage @KateNWang researchers ask: Should we diagnose Mild Cognitive Impairment (#MCI)? What are the risk…
#NeuroTPA @AmyTPage @KateNWang researchers ask: Should we diagnose Mild Cognitive Impairment (#MCI)? What are the risks/benefits? How will a diagnosis benefit the patient? #TPATuesday https://t.co/s4CtwUQvfx https://t.co/9rRLoY2awn
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
RT @AgeingJ: Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
Mild cognitive impairment: To diagnose or not to diagnose https://t.co/O12lhNgLev
RT @AmyTPage: Is Mild Cognitive Impairment a diagnosis that's useful to patients? @KateNWang @cd_ethertonbeer https://t.co/sV3T3qzrO0
Is Mild Cognitive Impairment a diagnosis that's useful to patients? @KateNWang @cd_ethertonbeer https://t.co/sV3T3qzrO0